Skip to content

Survey of Present Status of Diagnosis and Treatment

Survey of Present Status of Diagnosis and Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048581
Enrollment
Unknown
Registered
2021-07-11
Start date
2021-07-20
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

Patient group::No
Control group:No

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient group: 1. Meet the diagnostic criteria for rosacea; 2. The subject or the subject's guardian signed the informed consent; 3. No other serious systemic diseases. control group: 1. Non-rosacea patients from the same hospital as rosacea patients; 2. Match with the gender, age and geographical environment of rosacea patients; 3. No facial skin diseases such as sensitive skin, acne, skin lupus erythematosus, seborrheic dermatitis, etc.; 4. No systemic autoimmune disease or other serious systemic disease.

Exclusion criteria

Exclusion criteria: 1. Other facial inflammatory or infectious skin diseases; 2. Patients who are considered unsuitable to participate in the trial by other investigators.

Design outcomes

Primary

MeasureTime frame
habits of cleaning and eating;

Countries

China

Contacts

Public ContactWu Yan

Peking University First Hospital

3437477565@qq.com+86 10 83573274

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026